A trigger model of apoptosis induced by tumor necrosis factor signaling

BMC Systems Biology

Volumn 5, Issue SUPPL. 1, 2011, Pages

  Gu, Chang ^a   Zhang, Junjie ^b   Chen, Yingyu ^a,c   Lei, Jinzhi ^d  

^a PEKING UNIVERSITY   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; DRUG EFFECT; ENZYME ACTIVATION; EXTRACELLULAR SPACE; KINETICS; METABOLISM; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASE 3; CASPASE 8; ENZYME ACTIVATION; EXTRACELLULAR SPACE; KINETICS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959196445     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-13     Document Type: Article

References (31)

1. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365. 10.1016/S0092-8674(00)81874-7, 9039262.
2. Eissing T, Conzelmann H, Gilles ED, Allgöwer F, Bullinger E, Scheurich P. Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem. 2004, 279:36892-36897. 10.1074/jbc.M404893200, 15208304.
3. Hengartner MO. The biochemistry of apoptosis. Nature 2000, 407:770-776. 10.1038/35037710, 11048727.
4. Vilćek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 1991, 266(12):7313-7316.
5. Camussi G, Albano E, Tetta C, Bussolino F. The molecular action of tumor necrosis factor-α. Eur. J. Biochem. 1991, 202:3-14. 10.1111/j.1432-1033.1991.tb16337.x, 1657606.
6. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998, 17:1675-1687. 10.1093/emboj/17.6.1675, 1170515, 9501089.
7. Roberston JD, Orrenius S, Zhivotovsky B. Review: Nuclear events in apoptosis. J. Struct. Biol. 2000, 129:346-358. 10.1006/jsbi.2000.4254, 10806085.
8. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J. Exp. Med. 1996, 183:1957-1964. 10.1084/jem.183.5.1957, 2192542, 8642305.
9. Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I. Bistability in apoptosis: Roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophysical Journal 2006, 90:1546-1559. 10.1529/biophysj.105.068122, 1367306, 16339882.
10. Bentele M, Lavrik I, Ulrich M, Stößer S, Heermann DW, Kalthoff H, Krammer PH, Eils R. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J. Cell Biol. 2004, 166:839-851. 10.1083/jcb.200404158, 2172102, 15364960.
11. Fussenegger M, Bailey J, Varner J. A mathematical model of caspase function in apoptosis. Nat. Biotech. 2000, 18:768-774.
12. Hua F, Cornejo MG, Cardone MH, Stokes CL, Lauffenburger DA. Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 2005, 175:985-995.
13. Legewie S, Blüthgen N, Herzel H, Hanspeter H. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comp. Biol. 2006, 2:1061-1073.
14. Okazaki N, Asano R, Kinoshita T, Chuman H. Simple computational models of typeI/typeII cells in Fas signaling-induced apoptosis. J. Theor. Biol. 2008, 250:621-633. 10.1016/j.jtbi.2007.10.030, 18067927.
15. Stucki J, Simon H. Mathematical modeling of the regulation of caspase-3 activation and degradation. J. Theor. Biol. 2005, 234:123-131. 10.1016/j.jtbi.2004.11.011, 15721041.
16. Geske FJ, Lieberman R, Strange R, Gerschenson LE. Early stages of p53-induced apoptosis are reversible. Cell Death Diff. 2001, 8:182-191.
17. Rodriguez-Lafrasse C, Alphonse G, Broquet P, Aloy MT, Louisot P, Rousson R. Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosis. Biochem. J. 2001, 357:407-416. 10.1042/0264-6021:3570407, 1221967, 11439090.
18. Tawa P, Hell K, Giroux A, Grimm E, Han Y, Nicholson DW, Xanthoudakis S. Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors. Cell Death Diff. 2004, 11:439-447.
19. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347. 10.1038/371346a0, 8090205.
20. Geske FJ, Nelson AC, Lieberman R, Strange R, Sun T, Gerschenson LE. DNA repair is activated in early stages of p53-induced apoptosis. Cell Death Diff. 2000, 7:393-401.
21. Boesen-de Cock JGR, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and γ-Radiation downstream from caspase-8 activation. J Biol Chem 1999, 274:14255-14261. 10.1074/jbc.274.20.14255, 10318846.
22. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996, 271:12687-12690. 10.1074/jbc.271.22.12687, 8663110.
23. Seol DW, Li J, Seol M, Park MH, Park SY, Talanian R, Billiar TR. Signaling events triggered by Tumor Necrosis Factor-Related Apoptosis-inducing Ligand (TRAIL): Caspase-8 is required for TRAIL-induced apoptosis. Cancer Res. 2001, 61:1138-1143.
24. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682. 10.1016/1074-7613(95)90057-8, 8777713.
25. Hetz CA, Hunn M, Rojas P, Torres V, Leyton L, Quest AFG. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delay ceremide increase. J. Cell Sci. 2002, 115:4671-4683. 10.1242/jcs.00153, 12415011.
26. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388:300-304. 10.1038/40901, 9230442.
27. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou Q, Sun C, Fesik SW, Liddington RC, Salvesen GS. Structural basis for the inhibition for caspase-3 by XIAP. Cell 2001, 104:791-800. 10.1016/S0092-8674(01)00274-4, 11257232.
28. Salvesen GS, Duckett CS. IAP proteins: Blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 2002, 3:401-410. 10.1038/nrm830, 12042762.
29. Zou H, Yang R, Hao J, Wang J, Sun C, Fesik SW, Wu JC, Tomaselli KJ, Armstronget RC. Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J. Biol. Chem. 2003, 278:8091-8098. 10.1074/jbc.M204783200, 12506111.
30. Irmler M, Thome M, Hahne M, Schnieder P, Hoffmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C, Rimoldi D, Frech LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195. 10.1038/40657, 9217161.
31. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber A, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Zörnig M, Lynch DH. The CD95 receptor: apoptosis revisited. Cell 2007, 129:447-450. 10.1016/j.cell.2007.04.031, 17482535.